These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22404720)

  • 1. Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma.
    Puoti C; Guarisco R; Spilabotti L; Bellis L; Mitidieri Costanza O; Dell' Unto O; Elmo MG
    J Viral Hepat; 2012 Apr; 19(4):229-35. PubMed ID: 22404720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.
    Puoti C; Bellis L; Guarisco R; Dell' Unto O; Spilabotti L; Costanza OM
    Eur J Intern Med; 2010 Apr; 21(2):57-61. PubMed ID: 20206870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV carriers with persistently normal ALT Levels: not too much healthy, not true patients.
    Puoti C
    Rom J Gastroenterol; 2004 Dec; 13(4):329-32. PubMed ID: 15624031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus with normal transaminase levels.
    Puoti C
    Dig Dis; 2007; 25(3):277-8. PubMed ID: 17827956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
    J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
    Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
    J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical management of asymptomatic HCV carriers].
    Nakamura I; Ochiai K; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):396-9. PubMed ID: 15359829
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural history of hepatitis C and the impact of anti-viral therapy.
    Boyer N; Marcellin P
    Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
    Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with hepatitis C and normal serum aminotransferase levels.
    Bacon BR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S179-84. PubMed ID: 12407592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral treatment of HCV carriers with persistently normal ALT levels.
    Puoti C; Bellis L; Galossi A; Guarisco R; Nicodemo S; Spilabotti L; Unto OD
    Mini Rev Med Chem; 2008 Feb; 8(2):150-2. PubMed ID: 18289098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic hepatitis C with normal level of alanine-aminotransferase].
    Rossi G
    Recenti Prog Med; 2004 Nov; 95(11):509-11. PubMed ID: 15598087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
    Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
    J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
    Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.